{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:08:58Z","timestamp":1766268538715},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/mnm.0b013e328362d2fb","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T11:10:28Z","timestamp":1372331428000},"page":"915-925","source":"Crossref","is-referenced-by-count":24,"title":["Estimated background doses of [67Ga]-DTPA-USPIO in normal Balb\/c mice as a potential therapeutic agent for liver and spleen cancers"],"prefix":"10.1097","volume":"34","author":[{"given":"Saeed","family":"Shanehsazzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.","family":"Oghabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsaneh","family":"Lahooti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed","family":"Abolghasem Haeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massoud","family":"Amanlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba J.","family":"Daha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210212","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1166\/jbn.2010.1119","article-title":"Potential use of nanoparticle based contrast agents in MRI: a molecular imaging perspective.","volume":"6","author":"Oghabian","year":"2010","journal-title":"J Biomed Nanotechnol"},{"key":"R2-11-20210212","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s10967-012-2173-4","article-title":"Biodistribution of ultrasmall superparamagnetic iron oxide nanoparticles in BALB mice.","volume":"295","author":"Shanehsazzadeh","year":"2013","journal-title":"J Radioanal Nucl Chem"},{"key":"R5-11-20210212","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1166\/asem.2013.1214","article-title":"Effect of coating materials on lymph nodes detection using magnetite nanoparticles.","volume":"5","author":"Oghabian","year":"2013","journal-title":"Adv Sci Eng Med"},{"key":"R6-11-20210212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/0971-6203.106603","article-title":"Evaluating the effect of ultrasmall superparamagnetic iron oxide nanoparticles for a long-term magnetic cell labeling.","volume":"38","author":"Shanehsazzadeh","year":"2013","journal-title":"J Med Phys"},{"key":"R8-11-20210212","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1016\/S1076-6332(03)80210-6","article-title":"Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents.","volume":"9","author":"Wunderbaldinger","year":"2002","journal-title":"Acad Radiol"},{"key":"R9-11-20210212","doi-asserted-by":"crossref","first-page":"349408","DOI":"10.1155\/2013\/349408","article-title":"Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen.","volume":"2013","author":"Shahbazi-Gahrouei","year":"2013","journal-title":"Biomed Res Int"},{"key":"R10-11-20210212","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MNM.0b013e32835aa7bd","article-title":"Preparation of radioactive praseodymium oxide as a multifunctional agent in nuclear medicine: expanding the horizons of cancer therapy using nanosized neodymium oxide.","volume":"34","author":"Bakht","year":"2013","journal-title":"Nucl Med Commun"},{"key":"R11-11-20210212","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jmmm.2009.02.086","article-title":"How size evaluation of lymph node is protocol dependent in MRI when using ultrasmall superparamagnetic iron oxide nanoparticles.","volume":"321","author":"Gharehaghaji","year":"2009","journal-title":"J Magn Magn Mater"},{"key":"R13-11-20210212","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1166\/jnn.2011.3775","article-title":"Detectability of Her2 positive tumors using monoclonal antibody conjugated iron oxide nanoparticles in MRI.","volume":"11","author":"Oghabian","year":"2011","journal-title":"J Nanosci Nanotechnol"},{"key":"R14-11-20210212","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1016\/j.biomaterials.2011.05.035","article-title":"A metabonomic analysis of organ specific response to USPIO administration.","volume":"32","author":"Feng","year":"2011","journal-title":"Biomaterials"},{"key":"R15-11-20210212","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.nano.2009.11.005","article-title":"Detection sensitivity of lymph nodes of various sizes using USPIO nanoparticles in magnetic resonance imaging.","volume":"6","author":"Oghabian","year":"2010","journal-title":"Nanomedicine"},{"key":"R16-11-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/rpd\/ncs137","article-title":"Assessment of effective absorbed dose of 111In-DTPA-buserelin in human on the basis of biodistribution rat data.","volume":"154","author":"Lahooti","year":"2012","journal-title":"Radiat Prot Dosimetry"},{"key":"R17-11-20210212","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/rpd\/ncq172","article-title":"Determination of human absorbed dose of 201Tl(III)-DTPA-HIgG based on biodistribution data in rats.","volume":"141","author":"Khorrami Moghaddam","year":"2010","journal-title":"Radiat Prot Dosimerty"},{"key":"R18-11-20210212","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1524\/ract.2010.1689","article-title":"Development of 111In-DTPA-buserelin for GnRH receptor studies.","volume":"98","author":"Jalilian","year":"2010","journal-title":"Radiochimica Acta"},{"key":"R19-11-20210212","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1524\/ract.2008.1512","article-title":"Preparation and evaluation Ga-67-DTPA-beta-1-24-corticotrophin in normal rats.","volume":"96","author":"Jalilian","year":"2008","journal-title":"Radiochimica Acta"},{"key":"R20-11-20210212","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MNM.0b013e328340b916","article-title":"Estimation of human effective absorbed dose of 67Ga-cDTPA-gonadorelin based on biodistribution rat data.","volume":"32","author":"Shanehsazzadeh","year":"2011","journal-title":"Nucl Med Commun"},{"key":"R21-11-20210212","first-page":"S326","article-title":"Development of 67Ga-DTPA-gonadorelin in normal rats.","volume":"52","author":"Shanehsazzadeh","year":"2009","journal-title":"J Labelled Compd Rad"},{"key":"R22-11-20210212","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/rpd\/ncp085","article-title":"Determination of human absorbed dose of 67GA-DTPA-ACTH based on distribution data in rats.","volume":"134","author":"Shanehsazzadeh","year":"2009","journal-title":"Radiat Prot Dosimetry"},{"key":"R24-11-20210212","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/cbr.2005.20.126","article-title":"Establishing a clinically meaningful predictive model of hematologic toxicity in nonmyeloablative targeted radiotherapy: practical aspects and limitations of red marrow dosimetry.","volume":"20","author":"Siegel","year":"2005","journal-title":"Cancer Biother Radiopharm"},{"key":"R29-11-20210212","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue.","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"R30-11-20210212","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10967-010-0488-6","article-title":"Study of magnetic ferrite nanoparticles labeled with 99mTc-pertechnetate.","volume":"284","author":"Wang","year":"2010","journal-title":"J Radioanal Nucl Chem"},{"key":"R31-11-20210212","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/jmri.1880070629","article-title":"Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages.","volume":"7","author":"Moore","year":"1997","journal-title":"JMRI - J Magn Reson Imaging"},{"key":"R34-11-20210212","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/08982109409018613","article-title":"New approaches in the chemical design of Gd-containing liposomes for use in magnetic resonance imaging of lymph nodes.","volume":"4","author":"Trubetskoy","year":"1994","journal-title":"J Liposome Res"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0b013e328362d2fb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:19:32Z","timestamp":1620962372000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201309000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328362d2fb","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}